Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

University announces £10m investment in animal science
The deal will bring to market new veterinary vaccines and tools for diagnosing diseases that affect farmed animals.

Deal will bring new veterinary vaccines to market

The University of Edinburgh has secured an investment of £10 million to bring animal science innovations to market.

The investment in a new company, Roslin Technologies, will develop business opportunities arising from research from the University of Edinburgh’s Roslin Institute and Royal (Dick) School of Veterinary Studies.

The deal will enable researchers to explore the commercial potential of technologies that enable low-cost manufacturing of new medicines using chicken eggs.

It will also bring to market new veterinary vaccines and tools for diagnosing diseases that affect farmed animals.

“This investment recognises the strength of the University’s innovation capacity and cements our position as one of the world’s leading research-intensive universities,” said Sir Timothy O’Shea, principal and vice-chancellor of the University of Edinburgh.

Professor Bruce Whitelaw, interim director of The Roslin Institute, added: “The Roslin Institute is internationally recognised for providing a strategic research base for large animal genetics and health science within the UK.

“Having pioneered the commercialisation of animal biotechnology for three decades, the establishment of Roslin Technologies now provides an exciting platform to accelerate the translation of Roslin’s data-driven innovations into the commercial sector.”

Roslin Technologies Ltd is thought to be the largest agriculture biotechnology start-up in UK history to focus on research projects aimed at improving animal health and raising agricultural productivity.

The company is a collaboration between the University, private equity advisors JB Equity and the British Innovation Fund, a newly-formed fund that invests in leading innovation venture funds and companies from British universities.

Image (C) University of Edinburgh

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.